Core Viewpoint - YS Biopharma Co., Ltd. is convening an extraordinary general meeting (EGM) on February 16, 2024, to remove six current board members and elect four new directors, led by founder Yi Zhang, who holds approximately 52% of the company's shares [1][4][13]. Group 1: EGM Details - The EGM is scheduled for February 16, 2024, at 9:00 a.m. Pacific Standard Time, at the offices of DLA Piper LLP in Seattle, WA [5][10]. - Shareholders of record as of February 8, 2024, are entitled to vote at the EGM [1][14]. - The meeting aims to approve the removal of six directors and the election of four new directors [5][13]. Group 2: Current and Proposed Directors - The directors proposed for removal include Mr. Hui Shao, Mr. Bo Tan, Dr. Ajit Shetty, Dr. Viren Mehta, Mr. Shaojing Tong, and Ms. Rachel Yu [5][13]. - The new director nominees are Ms. Nan Zhang, Ms. Yun (Monica) Zhang, Mr. Lui Chi Keung (Peter), and Mr. Jing Xian Li [5][23][24][26][27]. Group 3: Shareholder Voting Rights - As of the record date, YS Biopharma had 93,058,197 ordinary shares outstanding, with each share entitled to one vote [14][18]. - A quorum for the EGM requires shareholders holding at least one-third of the votes to be present [18]. - A simple majority (50.1%) of the votes cast is needed to adopt the ordinary resolutions at the EGM [18].
Shareholders of YS Biopharma Announce an Extraordinary General Meeting